Target intelligence / Profile preview

Tubulin tyrosine ligase-like protein 9 (TTLL9)

Target
TTLL9
Molecular classification
Enzyme
01

Overview

Tubulin tyrosine ligase-like protein 9 (TTLL9) is a probable tubulin polyglutamylase enzyme that generates side chains of glutamate on the gamma-carboxyl group of specific glutamate residues within the C-terminal tail of tubulin proteins[1][5]. This enzymatic modification, known as polyglutamylation, primarily affects microtubule structure and function, contributing to cellular processes such as flagellated sperm motility and the establishment of microtubule heterogeneity, especially within motile cilia[1][5][6]. TTLL9 is most likely functionally active as part of a protein complex, as it lacks some domains necessary for autonomous activity; its closest paralog is TTLL1[1]. Diseases associated with TTLL9 include primary ciliary dyskinesia and urocanase deficiency[1]. TTLL9 is predicted to localize to the cytoplasm, microtubules, and motile cilia, participating in protein modification and cytoskeletal organization[1][6]. No known drugs currently target TTLL9, and there is no indication that TTLL9 is a direct therapeutic target.

Other names
Tubulin tyrosine ligase like 9C20orf125probable tubulin polyglutamylase TTLL9dJ310O13.1Tubulin--tyrosine ligase-like protein 9tubulin-tyrosine ligase-like family, member 9
02

Biological functions

Microtubule polyglutamylationMicrotubule cytoskeleton organizationProtein polyglutamylationFlagellated sperm motility
03

Disease associations

Primary ciliary dyskinesiaUrocanase deficiencyOther (potential role in cilia-related disorders)

Beyond the preview

Go deeper on Tubulin tyrosine ligase-like protein 9 (TTLL9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tubulin tyrosine ligase-like protein 9 (TTLL9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call